Rare diseases
Investigational molecules
Locations
Back to Greece39 clinical trials in Cholargos, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
GreeceStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
GreeceStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
GreeceStudy of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer
GreeceStudy of Atezolizumab, Carboplatin, and Etoposide with or Without Tiragolumab for Patients with Untreated Extensive-Stage Small Cell Lung Cancer
GreeceStudy on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
GreeceStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GreeceStudy Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability
GreeceStudy of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy
GreeceStudy on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
GreeceStudy Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments
GreeceStudy of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
GreeceThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including investigations of targeted therapies and immunotherapy combinations.
Research focuses on improving survival rates and treatment effectiveness for patients with various stages of lung cancer.
Innovative clinical trials examining treatments for HER2-positive and estrogen receptor-positive breast cancer, with particular attention to early-stage and metastatic conditions.
Studies aim to enhance treatment outcomes and reduce recurrence risks in breast cancer patients.
Advanced research into bladder cancer and metastatic prostate cancer, exploring innovative combination therapies and novel treatment approaches.
Trials focus on improving treatment outcomes for patients with advanced urological malignancies.
Studies investigating treatments for advanced colorectal cancer, particularly focusing on specific genetic mutations and targeted therapies.
Research aims to develop personalized treatment approaches based on genetic profiles.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
